Clinical Trials on Normal Human Subjects

Total 12239 results

Reckitt Benckiser Inc.

Completed

Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h

Healthy Subjects
GlycoMimetics Incorporated
Quotient Sciences

Completed

A Study in Healthy Volunteers to Investigate How Much Test Medicine [14C]-Uproleselan is Taken up by the Body When Administered Directly Into the Vein (IV)

Healthy Subjects

United Kingdom
Procter and Gamble

Completed

Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy Study 2

Healthy Subjects

United States
Amgen

Completed

Study to Evaluate the Effect of Erenumab on Blood Pressure When Given Concomitantly With Subcutaneous Sumatriptan

Healthy Subjects

Belgium
Hanlim Pharm. Co., Ltd.

Completed

A Dose-escalation Clinical Trial After Multiple Dosing of HL217 Eye Drop in Healthy Male Subjects

Healthy Subjects

France
Reckitt Benckiser LLC

Completed

Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release Tablet

Healthy Subjects
Eisai Inc.
Purdue Pharma LP

Completed

Study to Assess the Pharmacokinetic Drug-Drug Interactions of Lemborexant When Coadministered With an Oral Contraceptive, Famotidine, or Fluconazole in Healthy Subjects

Healthy Subjects

United States
Eisai Co., Ltd.

Completed

Pharmacokinetic Study of Perampanel in Chinese Healthy Subjects

Healthy Subjects

China
Innosparks Pte Ltd.
National University Hospital, Singapore; KK Women's and Children's Hospital

Completed

A Randomised Crossover Study to Explore the Physiological Impact of AIR+ Smart Masks on Children

Healthy Subjects

Singapore
Beckman Coulter, Inc.

Completed

DxH520 Pediatric Reference Interval Verification

Healthy Subjects

Canada
Idorsia Pharmaceuticals Ltd.

Completed

Clinical Study to Assess the Pharmacokinetics, Safety, and Tolerability of ACT-129968 in Healthy Subjects

Healthy Subjects

Germany
Idorsia Pharmaceuticals Ltd.

Completed

A Study of ACT-541468 in Healthy Japanese and Caucasian Subjects

Healthy Subjects

Netherlands
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ACT-541468 in Healthy Young Adults and Elderly Subjects

Healthy Subjects

Netherlands
Idorsia Pharmaceuticals Ltd.

Completed

A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body

Healthy Subjects

United States
AstraZeneca

Completed

A Ph 1 Study of Epanova® in Healthy Chineses

Healthy Subjects

China
HK inno.N Corporation

Completed

Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers

Healthy Subjects

Korea, Republic of
Lyric Pharmaceuticals

Completed

A Study to Assess Ulimorelin in Healthy Subjects

Healthy Subjects
Tonix Pharmaceuticals, Inc.

Completed

Steady-State Pharmacokinetic Comparison Study of TNX-102 SL 5.6 mg Versus AMRIX® 30 mg ER Capsules

Healthy Subjects

Canada
Cortexyme Inc.

Completed

Study of COR388 HCl in Healthy Subjects

Healthy Subjects

United States
Reckitt Benckiser Healthcare (UK) Limited

Terminated

Gamma Scintigraphy Study to Investigate Tablet Disintegration in Healthy Volunteers.

Healthy Subjects
Pfizer

Completed

Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development

Healthy Subjects

United States
Curadim Pharma Co., Ltd.

Unknown

A First-in-human Phase 1 Study of CP1050

Healthy Subjects

United Kingdom
AstraZeneca

Completed

A Phase I Study to Assess PK of AZD7986 Alone & With Verapamil, Itraconazole or Diltiazem in Healthy Subjects

Healthy Subjects

United Kingdom
Charite University, Berlin, Germany

Completed

Walking for Stress Reduction

Healthy Subjects

Germany
Diurnal Limited
Simbec Research

Completed

Comparison of Pharmacokinetics of Infacort® Versus Immediate-release Hydrocortisone

Healthy Subjects
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablet Under Fasting Conditions

Healthy Subjects
Da Volterra

Completed

Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy Volunteers

Healthy Subjects

France
Nicox Ophthalmics, Inc.
ORA, Inc.

Completed

A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution

Healthy Subjects

United States
Minerva Neurosciences

Completed

A Pharmacokinetic Study of Modified Release (MR) Formulations of MIN-101 in Healthy Subjects

Healthy Subjects

Ireland
Lee's Pharmaceutical Limited

Completed

Evaluation of a Percutaneous Optical Fibre Glucose Sensor (FiberSense System)

Healthy Subjects

Hong Kong
Norwegian University of Science and Technology

Completed

Cardiovascular Fitness and Venous Function in Trained and Untrained Subjects

Healthy Subjects

Norway
Egalet Ltd

Completed

Assessment of Nasal Deposition and Clearance of Ketorolac Solution Administered Using the Valois Nasal Spray Device

Healthy Subjects

United Kingdom
Verastem, Inc.

Completed

A Phase I, Open-label Study of Absorption, Metabolism, and Excretion of Defactinib (VS-6063) in Healthy Male Subjects

Healthy Subjects
Torrent Pharmaceuticals Limited

Completed

BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions

Healthy Subjects
University Hospital, Strasbourg, France

Terminated

Polyphenols and Endothelial Function

Sedentary Subjects

France
Actelion

Completed

Comparison of Two Dose Strengths of Selexipag in Healthy Adults

Healthy Subjects

Germany
Lund University
Anti-Diabetic Food Centre

Completed

On the Impact of Common Sweetening Agents on Glucose Regulation, Cognitive Functioning and Gut Microbiota

Healthy Subjects

Sweden
Pfizer

Completed

A Study of PF-06410293 Following Subcutaneous Administration Using A Prefilled Syringe Or A Prefilled Pen In Healthy Adult Subjects (B538-05)

Healthy Subjects

United States
University Hospital, Linkoeping

Completed

Effects of Red Wine on Cardiovascular Risk Factors in Humans

Healthy Subjects
Charite University, Berlin, Germany

Completed

Effects of Brain Stimulation During Daytime Nap on Memory Consolidation in Younger, Healthy Subjects

Healthy Subjects

Germany
Eisai Co., Ltd.

Completed

A Study of APD356 (Lorcaserin) in Healthy Japanese Adult Subjects

Healthy Subjects

Japan
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting Conditions

Healthy Subjects
Eisai Co., Ltd.

Completed

A Study to Assess Safety, Tolerability, and Pharmacokinetics of E2307 in Healthy Young and Elderly Japanese Subjects

Healthy Subjects

Japan
Eisai Inc.

Completed

A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion

Healthy Subjects

United States
Eisai Inc.

Completed

A Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects

Healthy Subjects

United States
Eisai Inc.

Completed

A Study to Demonstrate Bioequivalence Between a 12-mg Dose of an Oral Suspension Formulation of Perampanel and a 12-mg Tablet Formulation of Perampanel Under Fasted and Fed Conditions in Healthy Subjects

Healthy Subjects
Celgene Corporation

Completed

Effect of UV Exposure on the PD of Multiple Doses of CC-90001 and Pilot Food Effect Study

Healthy Subjects

United States
Astellas Pharma Europe B.V.

Completed

A Study to Investigate the Effect of Oral Doses of Pilocarpine on Salivary Secretion and Static Pupillometry in Healthy Subjects

Healthy Subjects

United Kingdom
LG Life Sciences

Completed

Pharmacokinetics and Safety Study of LBAL in Healthy Subjects

Healthy Subjects
Pfizer

Completed

A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07)) (B538-07)

Healthy Subjects

United States

3

Subscribe